{"id":46683,"date":"2022-07-28T15:02:26","date_gmt":"2022-07-28T13:02:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/"},"modified":"2022-07-28T15:02:26","modified_gmt":"2022-07-28T13:02:26","slug":"mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/","title":{"rendered":"Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022"},"content":{"rendered":"
\n

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report second quarter financial results on Thursday, August 4, 2022. That same day, Mirum will host a conference call to discuss the company\u2019s progress and priorities for 2022.\n<\/p>\n

<\/a><\/p>\n

\nConference call details:
\n
Thursday, August 4, 2022
\n
4:30 p.m. ET \/ 1:30 p.m. PT\n<\/p>\n

\nDial-in:
\n
U.S.\/Toll-Free: 1 (888) 510-2553
\n
International: 1 (646) 960-0473
\n
Passcode: 9354200\n<\/p>\n

\nYou may also access the call via webcast by visiting the Events & Presentations section<\/a> on Mirum\u2019s website. A replay of this webcast will be available for 30 days.\n<\/p>\n

\nAbout Mirum Pharmaceuticals, Inc.<\/b>\n<\/p>\n

\nMirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare liver diseases. Mirum\u2019s approved medication is LIVMARLI\u00ae (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Please view the warnings and precautions available in the Prescribing information or, for more information, visit LIVMARLI.com<\/a>.\n<\/p>\n

\nMirum\u2019s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. LIVMARLI, an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 clinical trial for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK<\/a> Phase 2b clinical trial for patients with biliary atresia. In addition, Mirum has an expanded access program<\/a> open across multiple countries for eligible patients with ALGS and PFIC.\n<\/p>\n

\nMirum has submitted a Marketing Authorization Application to the European Medicines Agency for LIVMARLI for the treatment of cholestatic liver disease in patients with Alagille syndrome.\n<\/p>\n

\nMirum\u2019s second investigational treatment, volixibat, an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the VISTAS<\/a> Phase 2b clinical trial for adults with primary sclerosing cholangitis, the OHANA<\/a> Phase 2b clinical trial for pregnant women with intrahepatic cholestasis of pregnancy, and the VANTAGE<\/a> Phase 2b clinical trial for adults with primary biliary cholangitis.\n<\/p>\n

\nFollow Mirum on Twitter<\/a>, Facebook<\/a>, LinkedIn<\/a> and Instagram<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
Erin Murphy
\n
media@mirumpharma.com<\/a>\n<\/p>\n

\nInvestor Contacts:
\n
Ian Clements, Ph.D.
\n
ir@mirumpharma.com<\/a>\n<\/p>\n

\nSam Martin
\n
Argot Partners
\n
ir@mirumpharma.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report second quarter financial results on Thursday, August 4, 2022. That same day, Mirum will host a conference call to discuss the company\u2019s progress and priorities for 2022. Conference call details: Thursday, August 4, 2022 4:30 p.m. ET \/ 1:30 p.m. PT … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46683","6":"format-standard","7":"category-industry"},"yoast_head":"\nMirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report second quarter financial results on Thursday, August 4, 2022. That same day, Mirum will host a conference call to discuss the company\u2019s progress and priorities for 2022. Conference call details: Thursday, August 4, 2022 4:30 p.m. ET \/ 1:30 p.m. PT ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-28T13:02:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220728005326\/en\/746217\/21\/Mirum_Inline_FullColor_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022\",\"datePublished\":\"2022-07-28T13:02:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/\"},\"wordCount\":371,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005326\\\/en\\\/746217\\\/21\\\/Mirum_Inline_FullColor_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/\",\"name\":\"Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005326\\\/en\\\/746217\\\/21\\\/Mirum_Inline_FullColor_RGB.jpg\",\"datePublished\":\"2022-07-28T13:02:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005326\\\/en\\\/746217\\\/21\\\/Mirum_Inline_FullColor_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005326\\\/en\\\/746217\\\/21\\\/Mirum_Inline_FullColor_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/","og_locale":"en_US","og_type":"article","og_title":"Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022 - Pharma Trend","og_description":"FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report second quarter financial results on Thursday, August 4, 2022. That same day, Mirum will host a conference call to discuss the company\u2019s progress and priorities for 2022. Conference call details: Thursday, August 4, 2022 4:30 p.m. ET \/ 1:30 p.m. PT ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-28T13:02:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220728005326\/en\/746217\/21\/Mirum_Inline_FullColor_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022","datePublished":"2022-07-28T13:02:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/"},"wordCount":371,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220728005326\/en\/746217\/21\/Mirum_Inline_FullColor_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/","url":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/","name":"Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220728005326\/en\/746217\/21\/Mirum_Inline_FullColor_RGB.jpg","datePublished":"2022-07-28T13:02:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220728005326\/en\/746217\/21\/Mirum_Inline_FullColor_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220728005326\/en\/746217\/21\/Mirum_Inline_FullColor_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mirum-pharmaceuticals-to-announce-second-quarter-2022-financial-results-and-host-conference-call-on-august-4-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Mirum Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46683"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46683\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}